Introduction In order to enable fast treatment response to anaphylactic reactions, adrenaline autoinjectors (AAI) have been developed and manufactured. It has been reported in several studies that administration technique is suboptimal. The primary purpose of this study was to review the nature and extent of the deficiencies in administration technique among patients, parents/caregivers and healthcare professionals. Methods Relevant publications were identified between 1998 and 2015 using two search methods: a keyword search in Embase, PubMed, British Nursing Index and Cumulative Index to Nursing and Allied Health Literature and a search of reference lists of relevant articles.
INTRODUCTION
Adrenaline auto-injectors (AAIs) are first-line treatment for anaphylaxis in the community. Prompt injection with adrenaline can be life-saving and abort the progression of the anaphylactic reaction, allowing time to seek formal medical assessment and management. The European Academy of Allergy and Clinical Immunology describes six absolute indications for the prescription of an AAI including food and latex anaphylaxis, exercise-induced anaphylaxis, idiopathic anaphylaxis, moderate-to-severe persistent asthma with food allergy, venom allergy or underlying mast cell disorder. 1 Unlike other allergic conditions, such as rhinitis and eczema, whose prevalence appears to be stabilising over the last decade, anaphylaxis appears to be increasing. 2 Rates of hospital admissions in the UK for all causes of anaphylaxis increased sevenfold between 1992 and 2012, while prescriptions for AAIs increased fourfold from 1998 to 2012. 3 Anaphylaxis is the cause of approximately 20 deaths each year in the UK. 4 AAI is the main emergency treatment for individuals experiencing anaphylaxis, but its effectiveness is largely reliant on correct administration. Over the last few years, studies have assessed healthcare professionals' (HCPs), patients' and parents' administration techniques and skills with respect to the emergency management of anaphylaxis. The primary purpose of this review was to assess the magnitude of the deficit in administration technique and to summarise which stages in the process of administering AAIs are most problematic. Reviewing data from a broad number of studies will help inform the development of AAI design and educational interventions for improving future utilisation.
METHODS

Search strategy
A systematic review of literature published between January 1998 and August 2015 was undertaken using four databases (Embase, PubMed, British Nursing Index and Cumulative Index to Nursing and Allied Health Literature) (see online supplementary appendix 1). Subsequently, a search of the reference lists from relevant papers was performed. No language restrictions were applied.
Inclusion and exclusion criteria
This review focused on studies that included an assessment of AAI technique (either by demonstration or questionnaire) in three populations: patients (paediatric and adult), parents/caregivers of children diagnosed with anaphylaxis and prescribed an AAI device and HCPs. Studies were eligible if they were quantitative in nature including crosssectional/observational studies, before-and-after studies or randomised controlled trials.
Study selection
Two reviewers (CJJ and AET) independently reviewed the titles and then abstracts of articles generated by the electronic bibliographic search, rejecting any articles that clearly did not meet eligibility criteria. There was no disagreement between reviewers regarding the eligibility of the studies, although both reviewers were unsure of inclusion of three studies. These were discussed with a third author (HS) and a consensus was reached. The Preferred Reporting Items for Systematic Review and Meta-Analyses 5 flow diagram was used to summarise the systematic review process (figure 1). The authors of relevant published conference abstracts were contacted to determine if full study details were available.
Data extraction
The process of AAI administration is frequently described by manufacturers and researchers as six-component steps (device recognition, removal of safety cap, selection of appropriate injection site, application of correct end of device to body, administration of adrenaline and retaining AAI in place). We adopted these commonly used steps to prepare a standardised data extraction form and extracted data from the papers on participants' ability relating to each of these steps (tables 1-3). One reviewer (AET) extracted the data with a second (CJJ) crosschecking 50% to ensure accuracy, which was high. In addition, we noted any additional skills or knowledge assessed (ie, checking expiry date of the AAI), and other factors that were associated with correct administration technique.
Assessment of study quality
All studies included in the systematic review were evaluated for quality using the mixed methods appraisal tool (MMAT). 6 The MMAT has proven to be an effective and practical quality assessment tool for systematic reviews, which include different study designs or mixed methods. 7 The tool consists of two screening questions followed by four criteria for the appraisal of study quality according to study design. The MMAT enabled all studies included in this review to be assessed within each of the methodological domains used. The MMAT scores range from 0% (no criterion is met) to 100% (all four criteria are met). Studies were assessed by one reviewer experienced in conducting quality assessments (CJJ). Twenty-five per cent of the studies were checked by a second reviewer (AET) with any disagreement being resolved by discussion until consensus was reached.
RESULTS
From 1434 studies, a total of 23 studies met the inclusion criteria (figure 1). Eight studies came from the UK, [8] [9] [10] [11] [12] [13] [14] [15] six from North America, [16] [17] [18] [19] [20] [21] four from Turkey, [22] [23] [24] [25] three from Australia [26] [27] [28] and two from Israel 29 30 (tables 1-3). Sixteen studies were cross-sectional, five were before-and-after studies, one was a longitudinal survey and one was a randomised controlled trial. Nineteen papers requested participants to demonstrate use of the AAI. Four studies used a questionnaire technique in which the participants responded to true/false questions or described their technique. The papers varied in their focus, four assessed the techniques and skills of patients only, eight focussed on parents/caregivers only and six papers focussed on HCPs only. Five studies had broader focus; four of which included patients and parents/caregivers, and one study included patients, parents/caregivers and HCPs. The findings of the studies are presented to reflect the three populations of interest: patients (9 studies), parents/caregivers (13 studies) and HCPs (7 studies), with studies reporting multiple populations presented in tables 1-3. The studies which employed a before-and-after design or randomised controlled trial of the effect of instruction on AAI technique were isolated in order to clearly reflect on these findings (table 4).
Patients
We identified nine studies (550 participants), which documented patient AAI administration technique; all were based in allergy clinic settings (table 1) . Administration assessments varied from five to nine steps. Overall, prior to receiving any instruction or demonstration as part of the study, 37% of patients were able to demonstrate or detail correct administration technique (range 6-74%). This rose to 77% overall for two studies, which reported a before-and-after instruction design (table 4). The most consistently reported error was the failure to hold the AAI in place for 10 s (step 6, table 1), followed by a failure to apply enough pressure to activate (step 5, table 1). Six studies reported whether patients had received previous training on how to use AAI, on average 71% patients reported either visual instruction using a trainer device or verbal instruction (range 11-100%). Five studies identified five patient-related factors associated with good AAI technique: being aged over 18 years, being trained by an allergy specialist, having an AAI for more than 2½ years, membership of a support group and having a history of severe anaphylaxis.
Parents/caregivers
We identified 13 studies documenting parental/caregiver AAI administration technique, 10 of which reported the number of parents/caregivers participating (1182 participants). Eleven studies were based in allergy clinics, one study recruited participants from local schools and another from support groups and a private allergy clinic. Out of the five studies which reported findings for both patients/caregivers and patients, three did not provide separate results for parents/caregivers and patients and report patients and parents/caregivers results together. Overall, prior to receiving any instruction or demonstration, 32% of parents/caregivers were able to demonstrate or detail correct administration technique (range 6%-57%). This average rose to 79% in the five studies, which reported a randomised trial or before-and-after instruction design in parents/caregivers (table 4) .
Among parents or caregivers, the most common errors were the same as those reported for patients; a failure to hold the AAI in place for 10 s (step 6), followed by a failure to apply enough pressure to activate (step 5) (table 2). Nine studies reported whether parents or caregivers had received training or demonstration on how to use AAI, on average 70% said they had received some form of training (range 11%-100%). Seven studies reported eight parental/caregiver-related factors that were associated with proper AAI administration technique: having a child with more serious reactions, an AAI for more than 2½ years, membership to a support group, an AAI prescribed from secondary care, an AAI prescribed by an allergy specialist, insect sting allergy and a training device with a Auvi-Q (audio-prompt) device.
Healthcare professionals
We identified seven studies which documented HCPs AAI administration technique (923 participants); two were based in primary care, two in paediatric departments and one each in an allergy clinic, community pharmacy and a medical conference (table 3) . Overall, 21% of HCPs were able to demonstrate proper AAI technique prior to receiving any demonstration or instruction. One study reported a before-and-after instruction study design and showed an increase from 18% to 65% in proper AAI technique among community pharmacists (table 4) . The most commonly reported error was the failure to hold the AAI in place for at least 10 s (step 6) (table 3) . Accidental digital injection would have occurred in 21% of participants. One study reported the risk of accidental digital injection reduced from 36% to 7% posteducation. Three studies reviewed how many HCPs provided training on AAI technique to their patients, which was 28% overall (range 19%-51%). In the two studies which looked at factors associated with proper AAI administration technique among HCPs, two factors were identified: being a pharmacist and having a more general awareness of anaphylaxis management (specifically asking patients about a management plan, advising patients to call an ambulance after administration and explaining the side effects of adrenaline).
Quality assessment
Of the 23 studies included in this systematic review, no studies scored 100%, 5 studies scored 75% (three criteria met), 9 scored 50% (two criteria met), 7 scored 25% (one criterion met) and 2 studies scored 0% (tables 1-3, see online supplementary appendix 2). Shortcomings in study quality were often found in the description of the sampling strategy used and the failure to include a sample size calculation. It was also difficult to ascertain the response rate of studies and any differences between responders and non-responders. Patients were often inadequately described and it was not always clear who the respondents were. Although most studies adequately reported how AAI administration was assessed, this varied significantly between studies.
DISCUSSION
Administration technique and skills in using AAI have been documented to be consistently deficient over the last 17 years across six different countries. Correct administration technique varied widely, but overall was 30% for patients, 32% for parents/caregivers and 21% for HCPs. For studies which employed a before-and-after design of the impact of training, correct technique was achieved in 77% of patients, 79% of caregivers and 65% of HCPs. Approximately 70% of patients and parents/caregivers reported receiving some form of AAI training, yet only 28% of HCPs reported providing training. The most consistently observed error common to all three populations was the failure to hold the device in place for the recommended time, and additionally for patients and parents/caregivers, the failure to apply enough pressure to activate. In addition to observing correct administration technique, 14 studies reported factors related to proper administration technique. For patients, being aged over 18 years, trained in AAI use by an allergist, prescription of an AAI for more than 30 months, history of severe anaphylaxis and membership of a support group were all related to better technique. In addition to those already mentioned, for parents/caregivers, having a training device with which to practice and using an Auvi-Q instead of an EpiPen or Anapen were also correlated with better administration technique. Pharmacists and other HCPs who had a greater general awareness of managing anaphylaxis also demonstrated better administration technique. This is the first systematic review to explicitly detail the deficiencies in HCPs', patients' and parents' and caregivers' AAI Table 4 Participants' adrenaline auto-injector (AAI) administration technique for studies including an instruction of AAI administration in design (studies are presented in chronological order) administration technique. This review also identified seven studies which used a study design to improve administration technique. Several educational approaches to improving technique were reported varying from a simple 2 min demonstration of administration using a training device to a multidisciplinary approach involving an individualised anaphylaxis management plan, followed by education from a clinical nurse specialist and a dietetic assessment to provide families with advice on food avoidance. The time between training and assessment varied from immediate to approximately 1 year indicating that some of the training techniques were effective at improving administration over a long-term period. The identification of these successful approaches are timely as the European Medicines Agency have released a call for better training tools recommended to support patients who use AAIs. 31 There are some limitations to the conclusions drawn from this review. Results in three studies were not separated to reflect administration techniques of the patients and parents/caregivers giving a total score for both, which could suggest why overall scores and most common errors were mirrored between these groups. Additionally, the estimates of correct administration technique may be optimistic for three reasons. First, the majority of participants in these studies were self-selected with often no description of differences between responders and nonresponders, and may reflect responder bias. However, we know from a recent study involving mothers of non-allergic children with no previous experience of AAIs that only 15% were able to administer the device, 32 a figure which falls in the range of correct administration scores by experienced parents/caregivers found in this systematic review (6%-57%). Second, although the majority of studies used demonstration to assess administration (82%), self-reported questionnaires were used in the remaining studies indicating that findings may not reflect actual behaviour. Third, it is difficult to capture how the high pressure situation of a 'real-life' anaphylaxis emergency would impact AAI administration technique compared with the more controlled scenarios proposed in the research setting.
In relation to the scores used to determine correct technique in studies, these varied from zero to nine steps with some items not directly related or not critical to administration (ie, awareness of an expiry date), which may under-represent ability to administer device. The studies included in this systematic review related predominantly, but not exclusively, to one particular device (EpiPen). The introduction of newer AAIs such as the nextgeneration EpiPen, Jext, Emerade and Auvi-Q may impact on future assessments, although the majority of these devices use the same/similar injecting mechanisms. The most recent study in this review compared AAI use between devices and found that when prescribed a new device without receiving specific training, successful administration rates for mothers were higher with Auvi-Q (an audio-prompt AAI) (93%) than other traditional devices (ie, EpiPen, Anapen, Jext) (49%). 15 It is likely that correct administration rates will increase if audio-prompt devices are made readily available. However, the steps identified as being most likely to be performed incorrectly (eg, holding the device for the recommended time and applying enough pressure to activate), are common to all AAIs and emphasising the importance of this to patients, parents/caregivers and HCPs during training is essential. Some may argue that the interval between triggering the device and removal of the needle need not be 10 s, as research has found that for the EpiPen, delivery time is 0.3 s. 33 However, there are no disadvantages to holding the device in place for a longer period as this discourages rapid removal and is consistent with the majority of manufacturer guidelines (EpiPen, Jext, Anapen), although the more recently introduced Auvi-Q recommends 5 s. Related to training, we observed a 2.5-fold increase in correct administration technique for patients and parents/ caregivers and threefold increase in HCPs emphasising the beneficial effect training can have on technique.
Two non-systematic short-cut reviews conducted in 2013 to determine knowledge of correct AAI use in parents of allergic children and doctors 34 35 failed to identify five key studies. Our more recent, robust and extensive systematic review involving four databases, including papers published in any language identified these five studies plus two more recently published studies. We also present evidence on the most commonly reported mistakes in administration technique, important for the design of future studies, which need to move away from documenting poor technique and towards interventions to improve administration technique. Furthermore, our systematic review differentiates between patients', parents' and caregivers' and HCPs' correct use of auto-injectors and identifies factors related to successful administration technique.
Clinical implications
The lack of correct administration technique among patients and parents/caregivers is worrying, but of greater concern is the variation in techniques observed among HCPs. Familiarity with epinephrine as the first-line response in the treatment of anaphylaxis was widespread, but fewer were able to detail correct auto-injector technique, suggesting that if prescribing AAI, HCPs could be misinforming or not informing patients how to use the device correctly. The latter is likely given the observation that the majority (70%) of patients and parents/caregivers received training on how to use the device, yet only 28% of HCPs included in this review reported providing training. It may be useful to identify those who provide training (if not the HCPs in this review), to ensure that their methods, knowledge and resources are up-to-date. Also, only five studies looked at recognition of symptoms of anaphylaxis or indications for using AAI with wide variation in those which reported results. Indications for AAI use are important to address during patient consultation to avoid either inappropriate use and consequent emergency admissions or more importantly, fatalities from the delayed administration of AAI. 36 Indicators of poor technique and ability were found among those patients who were instructed on the use of device or cared for by general practitioners or non-allergy specialists compared with those cared for by allergy specialists. Those cared for by an allergy specialist were more confident and more likely to carry and have the ability to activate the device. Other significant associations were found. For instance, several studies reported significant positive effects on technique and performance if the patient was a member of an allergy support group. Further work is underway to determine which aspects of support groups are important to patients in terms of knowing how and when to use their AAI, but highlights the importance of recommending patients to join support groups. There was no effect on performance in relation to the time interval since training was received. Specifically, two studies showed that correct technique was no more likely to be demonstrated if training had been received in the last 6 months or over 24 months. This demonstrates the necessity for thorough training in the use of the device at initial consultation.
Future studies
With this plethora of studies documenting poor administration technique, it is time to concentrate on identifying and designing interventions targeting these areas of poor technique highlighted. Patients and parents/caregivers should be involved in the design of training resources to ensure they are acceptable and understandable in order to address their learning needs. Among HCPs, training regarding the use of the device and how to communicate this effectively to patients should be addressed as well as ensuring training devices are available to supply to their patients. Successful educational materials and tools have been identified, but further studies should be conducted to determine the cost-effectiveness of these approaches. Further research is required to address other important issues such as poor retention of information (by HCPs and patients/caregivers) after training, the frequency of retraining needed and how to balance time needed to train versus HCPs' other time constraints.
